ID   PCAT2_HUMAN             Reviewed;         544 AA.
AC   Q7L5N7; A3KBM1; Q6MZJ6; Q9NX23;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   10-MAY-2017, entry version 125.
DE   RecName: Full=Lysophosphatidylcholine acyltransferase 2;
DE            Short=LPC acyltransferase 2;
DE            Short=LPCAT-2;
DE            Short=LysoPC acyltransferase 2;
DE            EC=2.3.1.23;
DE   AltName: Full=1-acylglycerol-3-phosphate O-acyltransferase 11;
DE            Short=1-AGP acyltransferase 11;
DE            Short=1-AGPAT 11;
DE            EC=2.3.1.51;
DE   AltName: Full=1-acylglycerophosphocholine O-acyltransferase;
DE   AltName: Full=1-alkylglycerophosphocholine O-acetyltransferase;
DE            EC=2.3.1.67;
DE   AltName: Full=Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;
DE            Short=Acetyl-CoA:lyso-PAF acetyltransferase;
DE            Short=Lyso-PAF acetyltransferase;
DE            Short=LysoPAFAT;
DE   AltName: Full=Acyltransferase-like 1;
DE   AltName: Full=Lysophosphatidic acid acyltransferase alpha;
DE            Short=LPAAT-alpha;
GN   Name=LPCAT2; Synonyms=AGPAT11, AYTL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=17182612; DOI=10.1074/jbc.M609641200;
RA   Shindou H., Hishikawa D., Nakanishi H., Harayama T., Ishii S.,
RA   Taguchi R., Shimizu T.;
RT   "A single enzyme catalyzes both platelet-activating factor production
RT   and membrane biogenesis of inflammatory cells. Cloning and
RT   characterization of acetyl-CoA:lyso-PAF acetyltransferase.";
RL   J. Biol. Chem. 282:6532-6539(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20363836; DOI=10.1194/jlr.M004762;
RA   Agarwal A.K., Garg A.;
RT   "Enzymatic activity of the human 1-acylglycerol-3-phosphate-O-
RT   acyltransferase isoform 11: upregulated in breast and cervical
RT   cancers.";
RL   J. Lipid Res. 51:2143-2152(2010).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21498505; DOI=10.1074/jbc.M110.202424;
RA   Moessinger C., Kuerschner L., Spandl J., Shevchenko A., Thiele C.;
RT   "Human lysophosphatidylcholine acyltransferases 1 and 2 are located in
RT   lipid droplets where they catalyze the formation of
RT   phosphatidylcholine.";
RL   J. Biol. Chem. 286:21330-21339(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Possesses both acyltransferase and acetyltransferase
CC       activities. Activity is calcium-dependent. Involved in platelet-
CC       activating factor (PAF) biosynthesis by catalyzing the conversion
CC       of the PAF precursor, 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-
CC       PAF) into 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF).
CC       Also converts lyso-PAF to 1-O-alkyl-2-acyl-sn-glycero-3-
CC       phosphocholine (PC), a major component of cell membranes and a PAF
CC       precursor. Under resting conditions, acyltransferase activity is
CC       preferred. Upon acute inflammatory stimulus, acetyltransferase
CC       activity is enhanced and PAF synthesis increases. Also catalyzes
CC       the conversion of 1-acyl-sn-glycero-3-phosphocholine to 1,2-
CC       diacyl-sn-glycero-3-phosphocholine. {ECO:0000269|PubMed:20363836,
CC       ECO:0000269|PubMed:21498505}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphocholine
CC       = CoA + 1,2-diacyl-sn-glycero-3-phosphocholine.
CC       {ECO:0000269|PubMed:20363836}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + 1-alkyl-sn-glycero-3-
CC       phosphocholine = CoA + 2-acetyl-1-alkyl-sn-glycero-3-
CC       phosphocholine. {ECO:0000269|PubMed:20363836}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate =
CC       CoA + 1,2-diacyl-sn-glycerol 3-phosphate.
CC       {ECO:0000269|PubMed:20363836}.
CC   -!- ENZYME REGULATION: Acetyltransferase activity is increased
CC       following acute inflammatory stimulation by lipopolysaccharide
CC       (LPS). Acyltransferase activity is unchanged (By similarity).
CC       {ECO:0000250}.
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21498505}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:21498505}. Golgi apparatus membrane
CC       {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.
CC       Lipid droplet {ECO:0000269|PubMed:21498505}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7L5N7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7L5N7-2; Sequence=VSP_019912;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase
CC       activity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91199.1; Type=Frameshift; Positions=44; Evidence={ECO:0000305};
CC       Sequence=CAE46034.1; Type=Frameshift; Positions=295; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB244718; BAF47696.1; -; mRNA.
DR   EMBL; AK000488; BAA91199.1; ALT_FRAME; mRNA.
DR   EMBL; BX641069; CAE46034.1; ALT_FRAME; mRNA.
DR   EMBL; BC002472; AAH02472.2; -; mRNA.
DR   CCDS; CCDS10753.1; -. [Q7L5N7-1]
DR   RefSeq; NP_060309.2; NM_017839.4. [Q7L5N7-1]
DR   RefSeq; XP_011521471.1; XM_011523169.2. [Q7L5N7-2]
DR   UniGene; Hs.460857; -.
DR   ProteinModelPortal; Q7L5N7; -.
DR   SMR; Q7L5N7; -.
DR   BioGrid; 120286; 5.
DR   IntAct; Q7L5N7; 3.
DR   STRING; 9606.ENSP00000262134; -.
DR   SwissLipids; SLP:000000279; -.
DR   iPTMnet; Q7L5N7; -.
DR   PhosphoSitePlus; Q7L5N7; -.
DR   SwissPalm; Q7L5N7; -.
DR   BioMuta; LPCAT2; -.
DR   DMDM; 74738601; -.
DR   EPD; Q7L5N7; -.
DR   MaxQB; Q7L5N7; -.
DR   PaxDb; Q7L5N7; -.
DR   PeptideAtlas; Q7L5N7; -.
DR   PRIDE; Q7L5N7; -.
DR   DNASU; 54947; -.
DR   Ensembl; ENST00000262134; ENSP00000262134; ENSG00000087253. [Q7L5N7-1]
DR   GeneID; 54947; -.
DR   KEGG; hsa:54947; -.
DR   UCSC; uc002eie.5; human. [Q7L5N7-1]
DR   CTD; 54947; -.
DR   DisGeNET; 54947; -.
DR   GeneCards; LPCAT2; -.
DR   HGNC; HGNC:26032; LPCAT2.
DR   HPA; HPA007891; -.
DR   HPA; HPA008433; -.
DR   MIM; 612040; gene.
DR   neXtProt; NX_Q7L5N7; -.
DR   OpenTargets; ENSG00000087253; -.
DR   PharmGKB; PA162394265; -.
DR   eggNOG; KOG4666; Eukaryota.
DR   eggNOG; ENOG410XSIQ; LUCA.
DR   GeneTree; ENSGT00390000004914; -.
DR   HOGENOM; HOG000234374; -.
DR   HOVERGEN; HBG060273; -.
DR   InParanoid; Q7L5N7; -.
DR   KO; K13510; -.
DR   OMA; TACCPEK; -.
DR   OrthoDB; EOG091G09LH; -.
DR   PhylomeDB; Q7L5N7; -.
DR   TreeFam; TF323244; -.
DR   BRENDA; 2.3.1.23; 2681.
DR   BRENDA; 2.3.1.51; 2681.
DR   BRENDA; 2.3.1.67; 2681.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   UniPathway; UPA00085; -.
DR   ChiTaRS; LPCAT2; human.
DR   GenomeRNAi; 54947; -.
DR   PRO; PR:Q7L5N7; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000087253; -.
DR   CleanEx; HS_LPCAT2; -.
DR   ExpressionAtlas; Q7L5N7; baseline and differential.
DR   Genevisible; Q7L5N7; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005795; C:Golgi stack; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005811; C:lipid particle; IDA:UniProtKB.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0047192; F:1-alkylglycerophosphocholine O-acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0047144; F:2-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0061024; P:membrane organization; ISS:UniProtKB.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; IDA:UniProtKB.
DR   GO; GO:0006663; P:platelet activating factor biosynthetic process; ISS:UniProtKB.
DR   CDD; cd00051; EFh; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00563; PlsC; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Acyltransferase; Alternative splicing; Calcium; Complete proteome;
KW   Endoplasmic reticulum; Golgi apparatus; Lipid biosynthesis;
KW   Lipid droplet; Lipid metabolism; Membrane; Metal-binding;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Polymorphism;
KW   Reference proteome; Repeat; Signal-anchor; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    544       Lysophosphatidylcholine acyltransferase
FT                                2.
FT                                /FTId=PRO_0000247058.
FT   TOPO_DOM      1     57       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     58     78       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     79    544       Lumenal. {ECO:0000255}.
FT   DOMAIN      391    426       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      428    463       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     404    415       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     441    452       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOTIF       146    151       HXXXXD motif.
FT   MOTIF       220    223       EGTC motif.
FT   VAR_SEQ       1    270       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019912.
FT   VARIANT     163    163       M -> I (in dbSNP:rs837550).
FT                                /FTId=VAR_027058.
SQ   SEQUENCE   544 AA;  60208 MW;  B823D86272A739C0 CRC64;
     MSRCAQAAEV AATVPGAGVG NVGLRPPMVP RQASFFPPPV PNPFVQQTQI GSARRVQIVL
     LGIILLPIRV LLVALILLLA WPFAAISTVC CPEKLTHPIT GWRRKITQTA LKFLGRAMFF
     SMGFIVAVKG KIASPLEAPV FVAAPHSTFF DGIACVVAGL PSMVSRNENA QVPLIGRLLR
     AVQPVLVSRV DPDSRKNTIN EIIKRTTSGG EWPQILVFPE GTCTNRSCLI TFKPGAFIPG
     VPVQPVLLRY PNKLDTVTWT WQGYTFIQLC MLTFCQLFTK VEVEFMPVQV PNDEEKNDPV
     LFANKVRNLM AEALGIPVTD HTYEDCRLMI SAGQLTLPME AGLVEFTKIS RKLKLDWDGV
     RKHLDEYASI ASSSKGGRIG IEEFAKYLKL PVSDVLRQLF ALFDRNHDGS IDFREYVIGL
     AVLCNPSNTE EIIQVAFKLF DVDEDGYITE EEFSTILQAS LGVPDLDVSG LFKEIAQGDS
     ISYEEFKSFA LKHPEYAKIF TTYLDLQTCH VFSLPKEVQT TPSTASNKVS PEKHEESTSD
     KKDD
//
